← Back to Cibo Flash
Earnings

Hua Medicine-B (02552) announced interim results

  • RevenueRMB3.8bn
  • Net profitRMB-30.2M
  • Profit attributable to ownersRMB-30.2M
  • Revenue YoY+74.3%
  • Net profit YoY-102.6%
  • Depreciation & amortisationHK$32.5M
  • Capital expenditureHK$-10.1M
  • Interest-bearing debtHK$3.0bn

Source Hua Medicine-B

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect